{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:44:25Z","timestamp":1793285065375,"version":"4.5.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001774","name":"New Jersey Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["HRD-1909824"],"award-info":[{"award-number":["HRD-1909824"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R00 045765"],"award-info":[{"award-number":["R00 045765"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Addiction Neuroscience"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.addicn.2023.100126","type":"journal-article","created":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T01:11:06Z","timestamp":1693098666000},"page":"100126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Recent advances in drug discovery efforts targeting the sigma 1 receptor system: Implications for novel medications designed to reduce excessive drug and food seeking"],"prefix":"10.1016","volume":"8","author":[{"given":"Liam G.","family":"Knowles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abanoub J.","family":"Armanious","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan H.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7890","key":"10.1016\/j.addicn.2023.100126_bib0004","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41586-021-04175-x","article-title":"Structures of the \u03c3(2) receptor enable docking for bioactive ligand discovery","volume":"600","author":"Alon","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.addicn.2023.100126_bib0051","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3389\/fphar.2017.00714","article-title":"The sigma-2 receptor selective agonist siramesine (Lu 28-179) decreases cocaine-reinforced pavlovian learning and alters glutamatergic and dopaminergic input to the striatum","volume":"8","author":"Klawonn","year":"2017","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.addicn.2023.100126_bib0081","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108409","article-title":"The Sigma-2 receptor \/transmembrane protein 97 (\u03c32R\/TMEM97) modulator JVW-1034 reduces heavy alcohol drinking and associated pain states in male mice","volume":"184","author":"Quadir","year":"2021","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.addicn.2023.100126_bib0106","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.biopsych.2018.03.014","article-title":"Prevalence and Correlates of DSM-5\u2013Defined Eating Disorders in a Nationally Representative Sample of U.S. Adults","volume":"84","author":"Udo","year":"2018","journal-title":"Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.addicn.2023.100126_bib0032","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.appet.2008.12.003","article-title":"Preliminary validation of the yale food addiction scale","volume":"52","author":"Gearhardt","year":"2009","journal-title":"Appetite"},{"key":"10.1016\/j.addicn.2023.100126_bib0033","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev-nutr-110420-111710","article-title":"Is food addictive? A review of the science","volume":"41","author":"Gearhardt","year":"2021","journal-title":"Annu Rev Nutr"},{"issue":"12","key":"10.1016\/j.addicn.2023.100126_bib0067","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/s41386-021-01052-z","article-title":"Sleep dysregulation in binge eating disorder and \"food addiction\": the orexin (hypocretin) system as a potential neurobiological link","volume":"46","author":"Mehr","year":"2021","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.addicn.2023.100126_bib0109","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrn.2017.130","article-title":"The dopamine motive system: implications for drug and food addiction","volume":"18","author":"Volkow","year":"2017","journal-title":"Nat Rev Neurosci"},{"issue":"5","key":"10.1016\/j.addicn.2023.100126_bib0021","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1093\/qjmed\/hcl030","article-title":"Recognizing alcohol and drug abuse in patients with eating disorders","volume":"99","author":"Conason","year":"2006","journal-title":"Qjm"},{"issue":"5","key":"10.1016\/j.addicn.2023.100126_bib0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/erv.2306","article-title":"Food addiction and bulimia nervosa","volume":"22","author":"Meule","year":"2014","journal-title":"Eur Eat Disord Rev"},{"issue":"10","key":"10.1016\/j.addicn.2023.100126_bib0080","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.3390\/nu6104552","article-title":"The prevalence of food addiction as assessed by the Yale Food Addiction Scale: a systematic review","volume":"6","author":"Pursey","year":"2014","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.addicn.2023.100126_bib0022","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3945\/jn.108.097691","article-title":"Symposium overview\u2013food addiction: fact or fiction?","volume":"139","author":"Corwin","year":"2009","journal-title":"J Nutr"},{"key":"10.1016\/j.addicn.2023.100126_bib0015","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.neubiorev.2021.10.043","article-title":"New directions in modelling dysregulated reward seeking for food and drugs","volume":"132","author":"Brown","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.addicn.2023.100126_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2023.110717","article-title":"Binge eating, overeating and food addiction: approaches for examining food overconsumption in laboratory rodents","volume":"123","author":"Brown","year":"2023","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"11","key":"10.1016\/j.addicn.2023.100126_bib0043","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.biopsych.2022.06.027","article-title":"Orexin reserve: a mechanistic framework for the role of orexins (hypocretins) in addiction","volume":"92","author":"James","year":"2022","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.addicn.2023.100126_bib0044","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/7854_2016_57","article-title":"A decade of orexin\/hypocretin and addiction: where are we now?","volume":"33","author":"James","year":"2017","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.addicn.2023.100126_bib0068","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-021-01052-z","article-title":"Sleep dysregulation in binge eating disorder and \"food addiction\": the orexin (hypocretin) system as a potential neurobiological link","author":"Mehr","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.addicn.2023.100126_bib120","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.tins.2021.09.002","article-title":"Orexin (hypocretin) and addiction","volume":"44","author":"Mehr","year":"2021","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.addicn.2023.100126_bib118","doi-asserted-by":"crossref","first-page":"146665","DOI":"10.1016\/j.brainres.2020.146665","article-title":"Introduction to the special issue: \"Making orexin-based therapies for addiction a reality: what are the steps from here?","volume":"1731","author":"James","year":"2020","journal-title":"Brain. Res."},{"key":"10.1016\/j.addicn.2023.100126_bib119","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41386-020-0619-x","article-title":"Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer?","volume":"45","author":"James","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.addicn.2023.100126_bib0028","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/00048674221106678","article-title":"Advancing translational neuroscience research for eating disorders","volume":"56","author":"Foldi","year":"2022","journal-title":"Aust N Z J Psychiatry"},{"issue":"2","key":"10.1016\/j.addicn.2023.100126_bib0003","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/osp4.619","article-title":"A pilot randomized controlled trial of liraglutide 3.0mg for binge eating disorder","volume":"9","author":"Allison","year":"2023","journal-title":"Obes Sci Pract"},{"issue":"6","key":"10.1016\/j.addicn.2023.100126_bib0078","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s42255-023-00812-z","article-title":"Gut hormone co-agonists for the treatment of obesity: from bench to bedside","volume":"5","author":"Nogueiras","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/j.addicn.2023.100126_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1063033","article-title":"The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies","volume":"14","author":"Jerlhag","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.addicn.2023.100126_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105847","article-title":"Assessing the role of ghrelin and the enzyme ghrelin O-acyltransferase (GOAT) system in food reward, food motivation, and binge eating behavior","volume":"172","author":"Micioni Di Bonaventura","year":"2021","journal-title":"Pharmacol Res"},{"issue":"8","key":"10.1016\/j.addicn.2023.100126_bib0110","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41386-021-01249-2","article-title":"Involvement of the ghrelin system in the maintenance and reinstatement of cocaine-motivated behaviors: a role of adrenergic action at peripheral \u03b21 receptors","volume":"47","author":"You","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.addicn.2023.100126_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175669","article-title":"Endocannabinoid system as a therapeutic target for psychostimulants relapse: a systematic review of preclinical studies","volume":"951","author":"Karimi-Haghighi","year":"2023","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.addicn.2023.100126_bib0108","first-page":"11","article-title":"Exploring the therapeutic potential of cannabinoid receptor antagonists in inflammation, diabetes mellitus, and obesity","author":"Vasincu","year":"2023","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.addicn.2023.100126_bib0001","doi-asserted-by":"crossref","DOI":"10.1530\/JME-19-0138","article-title":"The sigma-1 receptor as key common factor in cocaine and food-seeking behaviors","volume":"63","author":"Aguinaga","year":"2019","journal-title":"J Mol Endocrinol"},{"issue":"3","key":"10.1016\/j.addicn.2023.100126_bib0057","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-3565(25)30536-7","article-title":"The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog","volume":"197","author":"Martin","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"issue":"21","key":"10.1016\/j.addicn.2023.100126_bib117","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1073\/pnas.80.21.6703","article-title":"Naloxone-inaccessible sigma receptor in rat central nervous system","volume":"80","author":"Tam","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"4849","key":"10.1016\/j.addicn.2023.100126_bib0101","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1126\/science.2832949","article-title":"Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems","volume":"240","author":"Su","year":"1988","journal-title":"Science"},{"issue":"5916","key":"10.1016\/j.addicn.2023.100126_bib0029","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1126\/science.1166127","article-title":"The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator","volume":"323","author":"Fontanilla","year":"2009","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.addicn.2023.100126_bib0013","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.celrep.2018.12.051","article-title":"Choline is an intracellular messenger linking extracellular stimuli to IP(3)-evoked Ca(2+) signals through sigma-1 receptors","volume":"26","author":"Brailoiu","year":"2019","journal-title":"Cell Rep"},{"issue":"27","key":"10.1016\/j.addicn.2023.100126_bib0005","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1073\/pnas.1705154114","article-title":"Identification of the gene that codes for the \u03c3(2) receptor","volume":"114","author":"Alon","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1016\/j.addicn.2023.100126_bib0035","doi-asserted-by":"crossref","first-page":"8072","DOI":"10.1073\/pnas.93.15.8072","article-title":"Purification, molecular cloning, and expression of the mammalian sigma1-binding site","volume":"93","author":"Hanner","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"27","key":"10.1016\/j.addicn.2023.100126_bib0049","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1073\/pnas.1708155114","article-title":"Cloning the sigma(2) receptor: wandering 40 years to find an identity","volume":"114","author":"Kim","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.addicn.2023.100126_bib0093","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/nature17391","article-title":"Crystal structure of the human \u03c31 receptor","volume":"532","author":"Schmidt","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.addicn.2023.100126_bib0069","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-2952(01)00666-9","article-title":"Molecular cloning and pharmacological characterization of the rat sigma1 receptor","volume":"62","author":"Mei","year":"2001","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.addicn.2023.100126_bib0095","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1146\/annurev.biochem.73.011303.074134","article-title":"The mammalian unfolded protein response","volume":"74","author":"Schr\u00f6der","year":"2005","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.addicn.2023.100126_bib112","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3389\/fphar.2019.00528","article-title":"The Roles of intracellular chaperone proteins, sigma receptors, in parkinson\u2019s disease (PD) and major depressive disorder (MDD)","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0091","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1038\/s41467-017-02087-x","article-title":"The sigma-1 receptor modulates methamphetamine dysregulation of dopamine neurotransmission","volume":"8","author":"Sambo","year":"2017","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.addicn.2023.100126_bib114","first-page":"327","article-title":"Sigma receptors [\u03c3Rs]: biology in normal and diseased states","volume":"36","author":"Rousseaux","year":"2016","journal-title":"J. Recept. Signal Transduct. Res."},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0006","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(00)00014-2","article-title":"Immunocytochemical localization of the sigma(1) receptor in the adult rat central nervous system","volume":"97","author":"Alonso","year":"2000","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.addicn.2023.100126_bib0053","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S0026-895X(25)08945-X","article-title":"In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone","volume":"41","author":"Leysen","year":"1992","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0079","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1021\/acs.jmedchem.0c01964","article-title":"Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management","volume":"64","author":"Peng","year":"2021","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0019","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0014-2999(94)90453-7","article-title":"NE-100, a novel potent sigma ligand, preferentially binds to sigma 1 binding sites in guinea pig brain","volume":"251","author":"Chaki","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.addicn.2023.100126_bib0060","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0014-2999(95)00208-3","article-title":"Characterization of two novel sigma receptor ligands: antidystonic effects in rats suggest sigma receptor antagonism","volume":"280","author":"Matsumoto","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0002","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0028-3908(96)00161-X","article-title":"The pharmacology of the novel and selective sigma ligand, PD 144418","volume":"36","author":"Akunne","year":"1997","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.addicn.2023.100126_bib0008","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ejmech.2008.03.033","article-title":"1,4-Diazepanes derived from (S)-serine\u2013homopiperazines with improved sigma(1) (sigma) receptor affinity and selectivity","volume":"44","author":"Bedurftig","year":"2009","journal-title":"Eur J Med Chem"},{"issue":"12","key":"10.1016\/j.addicn.2023.100126_bib0027","doi-asserted-by":"crossref","first-page":"7926","DOI":"10.1021\/acs.jmedchem.0c02265","article-title":"Recent advances in the development of sigma receptor ligands as cytotoxic agents: a medicinal chemistry perspective","volume":"64","author":"Fallica","year":"2021","journal-title":"J Med Chem"},{"issue":"19","key":"10.1016\/j.addicn.2023.100126_bib0045","doi-asserted-by":"crossref","first-page":"8272","DOI":"10.1021\/jm300371c","article-title":"New positron emission tomography (PET) radioligand for imaging sigma-1 receptors in living subjects","volume":"55","author":"James","year":"2012","journal-title":"J Med Chem"},{"issue":"18","key":"10.1016\/j.addicn.2023.100126_bib0071","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.1021\/jm300894h","article-title":"Pd-catalyzed direct C-H bond functionalization of spirocyclic sigma1 ligands: generation of a pharmacophore model and analysis of the reverse binding mode by docking into a 3D homology model of the sigma1 receptor","volume":"55","author":"Meyer","year":"2012","journal-title":"J Med Chem"},{"issue":"8","key":"10.1016\/j.addicn.2023.100126_bib0084","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1111\/j.1476-5381.2012.01942.x","article-title":"Pharmacological properties of S1RA, a new sigma-1 receptor antagonist that inhibits neuropathic pain and activity-induced spinal sensitization","volume":"166","author":"Romero","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0096","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1208\/s12248-011-9311-8","article-title":"Synthesis and pharmacological characterization of a novel sigma receptor ligand with improved metabolic stability and antagonistic effects against methamphetamine","volume":"14","author":"Seminerio","year":"2012","journal-title":"AAPS J"},{"issue":"3","key":"10.1016\/j.addicn.2023.100126_bib0102","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002130051061","article-title":"Pharmacological profile of MS-377, a novel antipsychotic agent with selective affinity for sigma receptors","volume":"145","author":"Takahashi","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.addicn.2023.100126_bib0017","unstructured":"Cebrecos, J., Galvez, R., Albesa, N., MunozBlanco, J., Aguilar, J., Rojals, V.M., Casals, S., Sust, M., Vaqu\u00e9, A., Morte, A., Gasc\u00f3n, N., & PlataSalam\u00e1n, C. (2016). E52862, a first in class sigma\u2081 receptor antagonist, in chronic postsurgical neuropathic pain: an exploratory phase II clinical trial. 16th World Congree on Pain, Yokohama, Japan."},{"issue":"23","key":"10.1016\/j.addicn.2023.100126_bib0026","doi-asserted-by":"crossref","first-page":"14979","DOI":"10.1021\/acs.jmedchem.0c01575","article-title":"EST64454: a highly soluble sigma(1) receptor antagonist clinical candidate for pain management","volume":"63","author":"Diaz","year":"2020","journal-title":"J Med Chem"},{"issue":"12","key":"10.1016\/j.addicn.2023.100126_bib0040","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.2967\/jnumed.117.192641","article-title":"Biodistribution and radiation dosimetry of (18)F-FTC-146 in humans","volume":"58","author":"Hjornevik","year":"2017","journal-title":"J Nuclear Med"},{"issue":"8","key":"10.1016\/j.addicn.2023.100126_bib0007","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/dta.2156","article-title":"Quantification of highly selective sigma-1 receptor antagonist CM304 using liquid chromatography tandem mass spectrometry and its application to a pre-clinical pharmacokinetic study","volume":"9","author":"Avery","year":"2017","journal-title":"Drug Test Anal"},{"issue":"5","key":"10.1016\/j.addicn.2023.100126_bib0077","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.neuropharm.2005.04.016","article-title":"Involvement of sigma (sigma) receptors in the acute actions of methamphetamine: receptor binding and behavioral studies","volume":"49","author":"Nguyen","year":"2005","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.addicn.2023.100126_bib0098","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0014-2999(88)90058-1","article-title":"Cocaine binding at sigma receptors","volume":"149","author":"Sharkey","year":"1988","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.addicn.2023.100126_bib0055","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/jpet.105.084525","article-title":"Cocaine up-regulates Fra-2 and sigma-1 receptor gene and protein expression in brain regions involved in addiction and reward","volume":"314","author":"Liu","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0056","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1124\/jpet.108.141051","article-title":"Alterations in fos-related antigen 2 and sigma1 receptor gene and protein expression are associated with the development of cocaine-induced behavioral sensitization: time course and regional distribution studies","volume":"327","author":"Liu","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.addicn.2023.100126_bib0085","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00213-004-1814-x","article-title":"The sigma1 (sigma1) receptor activation is a key step for the reactivation of cocaine conditioned place preference by drug priming","volume":"175","author":"Romieu","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20133","key":"10.1016\/j.addicn.2023.100126_bib0061","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(03)01723-0","article-title":"Sigma receptors: potential medications development target for anti-cocaine agents","volume":"469","author":"Matsumoto","year":"2003","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.addicn.2023.100126_bib0036","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1124\/jpet.109.159244","article-title":"Regulation of sigma-1 receptors and endoplasmic reticulum chaperones in the brain of methamphetamine self-administering rats","volume":"332","author":"Hayashi","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0099","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00213-004-1779-9","article-title":"Sigma1 receptor upregulation after chronic methamphetamine self-administration in rats: a study with yoked controls","volume":"175","author":"Stefanski","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.addicn.2023.100126_bib0062","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0014-2999(00)00917-1","article-title":"N-alkyl substituted analogs of the sigma receptor ligand BD1008 and traditional sigma receptor ligands affect cocaine-induced convulsions and lethality in mice","volume":"411","author":"Matsumoto","year":"2001","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"10.1016\/j.addicn.2023.100126_bib0050","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00213-008-1425-z","article-title":"Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice","volume":"203","author":"Kitanaka","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"issue":"1\u20133","key":"10.1016\/j.addicn.2023.100126_bib0097","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2012.07.029","article-title":"Sigma receptor antagonists attenuate acute methamphetamine-induced hyperthermia by a mechanism independent of IL-1\u03b2 mRNA expression in the hypothalamus","volume":"691","author":"Seminerio","year":"2012","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0014-2999(98)00876-0","article-title":"Novel sigma receptor ligands attenuate the locomotor stimulatory effects of cocaine","volume":"365","author":"McCracken","year":"1999","journal-title":"Eur J Pharmacol"},{"issue":"11","key":"10.1016\/j.addicn.2023.100126_bib0105","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1007\/s00213-019-05268-2","article-title":"Sigma-1 receptor ligand PD144418 and sigma-2 receptor ligand YUN-252 attenuate the stimulant effects of methamphetamine in mice","volume":"236","author":"Tapia","year":"2019","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"10.1016\/j.addicn.2023.100126_bib0083","first-page":"49","article-title":"Involvement of sigma 1 receptor in the SSRI-induced suppression of the methamphetamine-induced behavioral sensitization and rewarding effects in mice","volume":"33","author":"Rahmadi","year":"2013","journal-title":"Nihon Shinkei Seishin Yakurigaku Zasshi"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0048","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1124\/jpet.116.232728","article-title":"Blockade of cocaine or \u03c3 receptor agonist self administration by subtype-selective \u03c3 receptor antagonists","volume":"358","author":"Katz","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"10.1016\/j.addicn.2023.100126_bib0038","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/npp.2012.224","article-title":"Self-administration of cocaine induces dopamine-independent self-administration of sigma agonists","volume":"38","author":"Hiranita","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.addicn.2023.100126_bib0058","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1038\/sj.npp.1301323","article-title":"Differential effects of sigma1 receptor blockade on self-administration and conditioned reinstatement motivated by cocaine vs natural reward","volume":"32","author":"Martin-Fardon","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.addicn.2023.100126_bib0034","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1523\/JNEUROSCI.06-06-01757.1986","article-title":"Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine","volume":"6","author":"Gundlach","year":"1986","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0066","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0306-4522(88)90024-3","article-title":"Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain","volume":"25","author":"McLean","year":"1988","journal-title":"Neuroscience"},{"issue":"Pt 7","key":"10.1016\/j.addicn.2023.100126_bib0030","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/brain\/awu107","article-title":"Pharmacological stimulation of sigma-1 receptors has neurorestorative effects in experimental parkinsonism","volume":"137","author":"Francardo","year":"2014","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0018","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0014-2999(88)90362-7","article-title":"Activation of the A10 mesolimbic system by the sigma-receptor agonist (+)SKF 10,047 can be blocked by rimcazole, a novel putative antipsychotic","volume":"154","author":"Ceci","year":"1988","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.addicn.2023.100126_bib0073","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1098-2396(199908)33:2<129::AID-SYN3>3.0.CO;2-E","article-title":"Acute and chronic administration of the selective sigma1 receptor agonist SA4503 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study","volume":"33","author":"Minabe","year":"1999","journal-title":"Synapse"},{"issue":"9","key":"10.1016\/j.addicn.2023.100126_bib0052","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1023\/A:1027361101419","article-title":"Sigma 1 receptor subtype is involved in the facilitation of cortical dopaminergic transmission in the rat brain","volume":"22","author":"Kobayashi","year":"1997","journal-title":"Neurochem Res"},{"issue":"3","key":"10.1016\/j.addicn.2023.100126_bib0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.biopsych.2010.07.026","article-title":"Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis","volume":"69","author":"Garc\u00e9s-Ram\u00edrez","year":"2011","journal-title":"Biol Psychiatry"},{"issue":"27","key":"10.1016\/j.addicn.2023.100126_bib0041","doi-asserted-by":"crossref","first-page":"11250","DOI":"10.1074\/jbc.M116.774075","article-title":"The sigma-1 receptor modulates dopamine transporter conformation and cocaine binding and may thereby potentiate cocaine self-administration in rats","volume":"292","author":"Hong","year":"2017","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.addicn.2023.100126_bib0086","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S0893-133X(01)00391-8","article-title":"Involvement of the sigma(1) receptor in cocaine-induced conditioned place preference: possible dependence on dopamine uptake blockade","volume":"26","author":"Romieu","year":"2002","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0037","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.113.208264","article-title":"Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats","volume":"348","author":"Hiranita","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.addicn.2023.100126_bib0039","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1124\/jpet.111.185025","article-title":"Decreases in cocaine self-administration with dual inhibition of the dopamine transporter and \u03c3 receptors","volume":"339","author":"Hiranita","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.addicn.2023.100126_bib0012","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12640-019-00134-7","article-title":"OSU-6162, a Sigma1R ligand in low doses, can further increase the effects of cocaine self-administration on accumbal D2R heteroreceptor complexes","volume":"37","author":"Borroto-Escuela","year":"2020","journal-title":"Neurotox Res"},{"key":"10.1016\/j.addicn.2023.100126_bib0011","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1106765","article-title":"Combined treatment with Sigma1R and A2AR agonists fails to inhibit cocaine self-administration despite causing strong antagonistic accumbal A2AR-D2R complex interactions: the potential role of astrocytes","volume":"16","author":"Borroto-Escuela","year":"2023","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.addicn.2023.100126_bib0090","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pharmthera.2018.01.009","article-title":"The sigma-1 receptor as a regulator of dopamine neurotransmission: a potential therapeutic target for methamphetamine addiction","volume":"186","author":"Sambo","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.addicn.2023.100126_bib0010","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.bbr.2015.03.065","article-title":"Sigma-1 receptor mediates acquisition of alcohol drinking and seeking behavior in alcohol-preferring rats","volume":"287","author":"Blasio","year":"2015","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0074","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsych.2003.07.008","article-title":"Functional polymorphisms in the sigma1 receptor gene associated with alcoholism","volume":"55","author":"Miyatake","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.addicn.2023.100126_bib0107","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.bbr.2015.10.013","article-title":"Ethanol-related behaviors in mice lacking the sigma-1 receptor","volume":"297","author":"Valenza","year":"2016","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.addicn.2023.100126_bib0063","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0091-3057(03)00002-9","article-title":"Involvement of the sigma 1 receptor in the motivational effects of ethanol in mice","volume":"74","author":"Maurice","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"issue":"7","key":"10.1016\/j.addicn.2023.100126_bib0082","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/acer.14635","article-title":"Antagonism of Sigma-1 receptor blocks heavy alcohol drinking and associated hyperalgesia in male mice","volume":"45","author":"Quadir","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"issue":"6","key":"10.1016\/j.addicn.2023.100126_bib0089","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/npp.2008.192","article-title":"The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking","volume":"34","author":"Sabino","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.addicn.2023.100126_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108214","article-title":"Sigma-1 antagonism inhibits binge ethanol drinking at adolescence","volume":"215","author":"Ruiz-Leyva","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/FBP.0b013e32834eafe6","article-title":"Influence of sigma-1 receptor modulators on ethanol-induced conditioned place preference in the extinction-reinstatement model","volume":"23","author":"Bhutada","year":"2012","journal-title":"Behav Pharmacol"},{"issue":"6","key":"10.1016\/j.addicn.2023.100126_bib0088","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/npp.2011.5","article-title":"Activation of \u03c3-receptors induces binge-like drinking in Sardinian alcohol-preferring rats","volume":"36","author":"Sabino","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"14","key":"10.1016\/j.addicn.2023.100126_bib0059","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/WNR.0b013e32835717c8","article-title":"Effect of \u03c3\u2081 receptor antagonism on ethanol and natural reward seeking","volume":"23","author":"Martin-Fardon","year":"2012","journal-title":"Neuroreport"},{"key":"10.1016\/j.addicn.2023.100126_bib0092","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/978-3-319-50174-1_9","article-title":"Sigma-1 receptor antagonists: a new class of neuromodulatory analgesics","volume":"964","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2017","journal-title":"Adv Exp Med Biol"},{"issue":"12","key":"10.1016\/j.addicn.2023.100126_bib0023","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1038\/npp.2012.89","article-title":"Antagonism of sigma-1 receptors blocks compulsive-like eating","volume":"37","author":"Cottone","year":"2012","journal-title":"Neuropsychopharmacology"},{"issue":"18","key":"10.1016\/j.addicn.2023.100126_bib0054","first-page":"23","article-title":"Differential responses to sigma-1 or sigma-2 receptor ablation in adiposity, fat oxidation, and sexual dimorphism","author":"Li","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.addicn.2023.100126_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pbb.2017.10.013","article-title":"A behavioral and pharmacological characterization of palatable diet alternation in mice","volume":"163","author":"Moore","year":"2017","journal-title":"Pharmacol Biochem Behav"},{"issue":"19","key":"10.1016\/j.addicn.2023.100126_bib0020","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1021\/acschemneuro.0c00456","article-title":"Novel highly potent and selective sigma1 receptor antagonists effectively block the binge eating episode in female rats","volume":"11","author":"Cifani","year":"2020","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"10.1016\/j.addicn.2023.100126_bib0024","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1021\/acschemneuro.9b00261","article-title":"Investigation of the role of chirality in the interaction with \u03c3 receptors and effect on binge eating episode of a potent \u03c3(1) antagonist analogue of spipethiane","volume":"10","author":"Del Bello","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.addicn.2023.100126_bib0103","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.112087","article-title":"Sigma-1 receptor antagonist, PD144418, selectively reduces female motivation for food during negative energy balance","volume":"373","author":"Tapia","year":"2019","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.addicn.2023.100126_bib0104","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbr.2019.01.011","article-title":"Sigma-1 receptor antagonist PD144418 suppresses food reinforced operant responding in rats","volume":"362","author":"Tapia","year":"2019","journal-title":"Behav Brain Res"},{"issue":"4","key":"10.1016\/j.addicn.2023.100126_bib0064","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0149-7634(02)00017-9","article-title":"Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity","volume":"26","author":"Maurice","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib121","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s10020-022-00517-1","article-title":"Activation of the sigma-1 receptor exerts cardioprotection in a rodent model of chronic heart failure by stimulation of angiogenesis","volume":"28","author":"Zhao","year":"2022","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.addicn.2023.100126_bib122","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s44192-023-00036-3","article-title":"Overview of the potential use of fluvoxamine for COVID-19 and long COVID","volume":"3","author":"Hashimoto","year":"2023","journal-title":"Discov. Ment. Health"},{"issue":"5","key":"10.1016\/j.addicn.2023.100126_bib0014","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s00213-023-06362-2","article-title":"Evidence of trospium's ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results","volume":"240","author":"Breier","year":"2023","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.addicn.2023.100126_bib116","doi-asserted-by":"crossref","first-page":"105390","DOI":"10.1016\/j.neuint.2022.105390","article-title":"Sigma-1 receptor: a potential target for the development of antidepressants","volume":"159","author":"Wang","year":"2022","journal-title":"Neurochem. Int."},{"issue":"11","key":"10.1016\/j.addicn.2023.100126_bib115","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s40263-022-00968-4","article-title":"Dextromethorphan\/Bupropion: first approval","volume":"36","author":"Keam","year":"2022","journal-title":"CNS Drugs"},{"issue":"10","key":"10.1016\/j.addicn.2023.100126_bib0025","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1139\/Y08-077","article-title":"Antidepressant-like effect of 17beta-estradiol: involvement of dopaminergic, serotonergic, and (or) sigma-1 receptor systems","volume":"86","author":"Dhir","year":"2008","journal-title":"Can J Physiol Pharmacol"},{"issue":"11","key":"10.1016\/j.addicn.2023.100126_bib0042","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/tri.13293","article-title":"The role of Sigma-1 receptor in sex-specific heat shock response in an experimental rat model of renal ischaemia\/reperfusion injury","volume":"31","author":"Hosszu","year":"2018","journal-title":"Transpl Int"}],"container-title":["Addiction Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277239252300069X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S277239252300069X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:13:11Z","timestamp":1757412791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S277239252300069X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":117,"alternative-id":["S277239252300069X"],"URL":"https:\/\/doi.org\/10.1016\/j.addicn.2023.100126","relation":{},"ISSN":["2772-3925"],"issn-type":[{"value":"2772-3925","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in drug discovery efforts targeting the sigma 1 receptor system: Implications for novel medications designed to reduce excessive drug and food seeking","name":"articletitle","label":"Article Title"},{"value":"Addiction Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addicn.2023.100126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100126"}}